TIPSS as therapeutic modality for umbilical hernia in patients with advanced liver disease
Jasmohan Singh Bajaj, Rajiv R. Varma – 6 January 2004
Pseudohypocalcemia after magnetic resonance imaging with gadolinium in patients with cirrhosis
Costas H. Kefalas, Natalie G.B. Murray, James J. Aguanno, William D. Dockery, Jeffrey S. Weinstein, Katherine Anderson, Goran B. Klintmalm – 6 January 2004 – Hypocalcemia in patients with cirrhosis may be due to a number of causes. We noted a relationship between injection with gadodiamide, a particular gadolinium chelate, during magnetic resonance imaging of the liver and the development of a falsely low serum total calcium level in a patient with cirrhosis. A cross‐reference and retrospective chart review identified 10 additional patients in whom this phenomenon was noted.
A matched comparison study of medical and psychiatric complications and anesthesia and analgesia requirements in methadone‐maintained liver transplant recipients
Robert M. Weinrieb, Rebecca Barnett, Kevin G. Lynch, Maria DePiano, Alfred Atanda, Kim M. Olthoff – 6 January 2004 – Approximately 85% of patients receiving methadone maintenance therapy (MMT) for opiate dependence in the United States are infected with hepatitis C virus (HCV). MMT is significantly underrepresented in most liver transplant programs, but the number of patients receiving MMT is increasing and few data are available to guide treatment.
Is minimal hepatic encephalopathy completely reversible following liver transplantation?
Christopher Rose, Rajiv Jalan – 6 January 2004
Serum phosphate is not a reliable early predictor of outcome in paracetamol induced hepatotoxicity
Khee Lim Ng, J.S. Davidson, Andrew J. Bathgate – 6 January 2004
Hepatic arterial anatomy for right liver procurement from living donors
Henkie P. Tan, Amadeo Marcos – 6 January 2004
Syndromic incidence of ovarian cancer after liver transplantation: Is breast cancer an antecedent risk?
Joseph F. Buell, E. Steve Woodle – 6 January 2004 – Ovarian cancer is the gynecologic malignancy with the highest number of deaths in the United States. Previous studies had found a decreased incidence of female gynecological malignancies after liver transplantation. In order to estimate the incidence of ovarian carcinoma after liver transplantation, we evaluated 1,708 consecutive liver transplant recipients from 1984 to 2001. Of them, 770 (43%) were female. Routine follow‐ups were performed at 1, 2, 5, and 10 years after transplantation. There were two cases of ovarian carcinoma.
Impact of pretransplant diagnosis of hepatocellular carcinoma on cadveric liver allocation in the era of MELD
Paul H. Hayashi, James F. Trotter, Lisa Forman, Marcelo Kugelmas, Tracy Steinberg, Paul Russ, Michael Wachs, Thomas Bak, Igal Kam, Gregory T. Everson – 6 January 2004 – The allocation system based on the Model for End‐stage Liver Disease (MELD) has led to more patients diagnosed with hepatocellular carcinoma (HCC) being transplanted. We hypothesized that more patients misdiagnosed with HCC are also being transplanted, leading to inappropriate organ allocation.
Harvesting the middle hepatic vein with a right hepatectomy does not increase the risk for the donor
Olivier Scatton, Jacques Belghiti, Federica Dondero, Diane Goere, Daniele Sommacale, Marylène Plasse, Alain Sauvanet, Olivier Farges, Valérie Vilgrain, Francois Durand – 6 January 2004 – The harvesting of the middle hepatic vein (MHV) with a right hepatectomy for living‐donor liver transplantation allows an optimal venous drainage for the recipient but can also have adverse effects for the donor.